id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-1919-0006,FDA,FDA-1978-N-1919,Letter from Blistex Inc. to FDA,Other,Letter(s),2009-01-06T05:00:00Z,2009,1,2009-01-06T05:00:00Z,,2019-05-30T19:37:02Z,,0,0,090000648059e5fe
FDA-1978-N-1919-0001,FDA,FDA-1978-N-1919,Skin Protectant Drug Products for Over-the-Counter Human Use; Notice of Proposed Rulemaking for Fever Blister and Cold Sore Treatment Drug Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2009-01-06T05:00:00Z,2009,1,1990-01-31T05:00:00Z,1990-06-01T03:59:59Z,2019-08-01T17:16:35Z,55 FR 3362,0,0,090000648059e5f4
FDA-1978-N-1919-0004,FDA,FDA-1978-N-1919,"Request for Extension from McColl & Associates, Inc.",Other,Request for Extension,2009-01-06T05:00:00Z,2009,1,2009-01-06T05:00:00Z,,2019-05-30T14:38:13Z,,0,0,090000648059e5fa
FDA-1978-N-1919-0011,FDA,FDA-1978-N-1919,"Attachment 2 - National Institutes of Health, Consensus Development Conference Statement Sunlight, Ultraviolet Radiation, and the Skin, dated May 8-10, 1989 re: Request for Hearing from Campbell Laboratories, Inc.",Supporting & Related Material,Background Material,2009-01-06T05:00:00Z,2009,1,,,2019-05-30T18:58:49Z,,0,0,09000064807e1bda
FDA-1978-N-1919-0012,FDA,FDA-1978-N-1919,"Attachment 6 - ""Fever Blisters and Canker Sores"" re: Request for Hearing from Campbell Laboratories, Inc.",Supporting & Related Material,Background Material,2009-01-06T05:00:00Z,2009,1,,,2019-05-30T19:17:06Z,,0,0,09000064807e1d05
FDA-1978-N-1919-0010,FDA,FDA-1978-N-1919,"Attachment 5 - ""See Attachment 1"" - [Blistex, Inc. - Comment]",Supporting & Related Material,C-Comment (Supporting and Related Material),2009-01-06T05:00:00Z,2009,1,,,2009-01-06T23:14:48Z,,0,0,09000064807e12bc
FDA-1978-N-1919-0005,FDA,FDA-1978-N-1919,"Letter from FDA/CDER Response to McColl & Associates, Inc.",Other,Letter(s),2009-01-06T05:00:00Z,2009,1,2009-01-06T05:00:00Z,,2019-05-30T19:31:55Z,,0,0,090000648059e5fc
FDA-1978-N-1919-0009,FDA,FDA-1978-N-1919,"Attachment 1 - ""Skin Protectant Drug Products for Over-the-Counter Human Use"" (FR Vol 43 No. 151 dated August 4, 1978) re: Comment from Blistex, Inc.",Supporting & Related Material,Background Material,2009-01-06T05:00:00Z,2009,1,,,2019-05-30T13:47:27Z,,0,0,09000064807e0ff9
FDA-1978-N-1919-0007,FDA,FDA-1978-N-1919,"Letter from FDA/CDER Response to Blistex, Inc.",Other,Letter(s),2009-01-06T05:00:00Z,2009,1,2009-01-06T05:00:00Z,,2019-05-30T19:43:44Z,,0,0,090000648059e5ff